Navigation Links
Class in Medical Technology

MADIT-CRT Trial Meets Primary Endpoint

... symptomatic, New York Heart Association (NYHA) class I and II(2) patients were enrolled in MADIT-CRT. ... It is the world's largest randomized NYHA class I/II CRT-D trial, with more than 1,800 patients ... failure. Currently, patients must be in NYHA class III/IV heart failure to be indicated for CRT-D ...

Research: Popular Diabetes Medications Associated with Increase in Bone Fractures

... while another study shed new light on a different class of drugs that faced increased scrutiny from the ... 2 diabetes patients not taking TZDs. TZDs -- a class of drugs used to control blood sugar -- are used ... previous case reports concerning the drug class that led to strong FDA warnings. Researchers ...

Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Association's 69th Scientific Sessions

... single agent that represents the first in a new class of selective serotonin 2C receptor agonists. The ... target G protein-coupled receptors, an important class of validated drug targets, and includes compounds ... lorcaserin's potential to be the first in a new class of agonists or treatment option; lorcaserin's ...

Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting

... myeloma. Carfilzomib is the first in a new class of selective, irreversible proteasome inhibitors ... Carfilzomib Carfilzomib is the first in a new class of selective, irreversible proteasome inhibitors. ... lead product, carfilzomib, is the first in a new class of selective, irreversible proteasome inhibitors. ...

Proteolix Presents Phase 1b/2 Clinical Data for Carfilzomib in Advanced Solid Tumor Patients at the 2009 ASCO Annual Meeting

... activity. Carfilzomib is the first in a new class of selective, irreversible proteasome inhibitors ... Carfilzomib Carfilzomib is the first in a new class of selective, irreversible proteasome inhibitors. ... lead product, carfilzomib, is the first in a new class of selective, irreversible proteasome inhibitors. ...

MitraClip(R) Therapy Data Demonstrate Clinical Benefit in High-Risk Patients With Mitral Regurgitation

... with matched data were in NYHA functional class I or II, compared to only 9 percent at baseline. ... with matched data were in NYHA functional class I or II, compared to only 15 percent at baseline. This sustained improvement in functional class was accompanied by improved LV function for both ...

FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia

... 5HT2A receptor antagonist, and belongs to the class of atypical antipsychotics. "The approval ... are often associated with some other drugs in the class of atypical antipsychotics. Similarly to ... of adverse events. Worldwide sales from the class of atypical antipsychotics exceeded US $20 ...

Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen

... histological evidence of cirrhosis (Child-Pugh class A) and patients with HIV disease that are ... histological evidence of cirrhosis (Child-Pugh class A). Alpha interferons, including ... decompensation (Child-Pugh score greater than 6; class B and C) in cirrhotic CHC monoinfected patients ...

Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C

... histological evidence of cirrhosis (Child-Pugh class A) and patients with HIV disease that are ... histological evidence of cirrhosis (Child-Pugh class A). Alpha interferons, including PEGASYS ... decompensation (Child-Pugh score greater than 6; class B and C) in cirrhotic CHC monoinfected patients ...

Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP

... Check, LLP: Notice is hereby given that a class action lawsuit was filed in the United States ... Plaintiff seeks to recover damages on behalf of class members and is represented by the law firm of ... Kessler Meltzer & Check which prosecutes class actions in both state and federal courts ...

Study of Cannabinoid Medicine for Pain Found Patients Got 'High,' but Effects Not Related to Pain Relief

... first to examine the addictive potential of this class of pain medicine, were presented today at the ... for non-cancer pain management, the cannabinoid class of medicines (such as dronabinol), got patients ... study we believe the addictive qualities of this class of medicines need more investigation. In our ...

New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients

... histological evidence of cirrhosis (Child-Pugh class A) and patients with HIV disease that are ... histological evidence of cirrhosis (Child-Pugh class A). Alpha interferons, including PEGASYS(R) ... decompensation (Child-Pugh score greater than 6; class B and C) in cirrhotic CHC monoinfected patients ...

Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections

... reductase (DHFR) selective inhibitor class of antibiotics, was specifically designed to ... reductase (DHFR) selective inhibitor class to demonstrate efficacy against cSSSIs caused by MRSA. The DHFR class has been proven safe and effective in more than ...

Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer

... of Shenzhen. The clinical trial produced best in class pharmacokinetics (PK), biomarker and safety ... and HBI-8000 in the US, is a novel, benzamide class histone deacetylase (HDAC) inhibitor discovered ... with Chidamide/HBI-8000, supporting a best in class safety profile. Results will be presented by ...

Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure

... in October 2007, targeting patients who fall into class II or III heart failure. The MARVEL Trial is ... not worsen, in Quality of Life or heart failure class while only 6-17 percent worsened. In comparison, ... in various countries in Europe for the sickest class III heart failure patients that continue to ...

Enanta Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital- and Community-Acquired MRSA

... Bicyclolide, a novel macrolide-related drug class with a distinct resistance profile. The clinical ... and drug discovery capabilities to create best in class small molecule drugs in the anti-infective field. ... Additionally, the Company has created a new class of macrolide antibiotics, called Bicyclolides, ...

FDA Lifts Clinical Hold on Genta's Tesetaxel, a Leading Oral Taxane

... semi-synthetic taxane that is in the same class of drugs as paclitaxel and docetaxel. However, ... prominent side-effects of this drug class include myelosuppression (low blood counts) and ... the high antitumor activity of the taxane drug class while eliminating infusion reactions, reducing ...

Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease

... hypertension (PAH) patients (WHO functional class II - WHO FC II), bosentan (Tracleer(R)) prevented ... addition, a significant delay in WHO functional class deterioration was observed in the bosentan group ... are four WHO functional classes for PAH with class I being the least severe ...

Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia

... with known hypersensitivity to tetracycline class antibiotics -- Glycylcycline class antibiotics are structurally similar to tetracycline class antibiotics and may have similar adverse effects. ...

Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center

... of the Kleberg Center. About LNATM LNAs are a class of nucleotide analogues that bind very strongly ... About miRNA microRNAs (miRNAs) are a novel class of regulatory RNA molecules with surprisingly ... regulation. Although recently identified as a class of molecules, initial studies indicate that ...

PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C

... histological evidence of cirrhosis (Child-Pugh class A) and patients with HIV disease that are ... histological evidence of cirrhosis (Child-Pugh class A). Alpha interferons, including PEGASYS(R) ... decompensation (Child-Pugh score greater than 6; class B and C) in cirrhotic CHC monoinfected patients ...

More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL

... with known hypersensitivity to tetracycline class antibiotics -- Glycylcycline class antibiotics are structurally similar to tetracycline class antibiotics and may have similar adverse effects. ...

Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008

... have an interferon-like mechanism and as a class may have a role as single agent therapy in some ... Nitazoxanide Nitazoxanide belongs to a new class of small molecule cell signaling modulators ... company, has discovered and developed a new class of small molecule antivirals known as ....

Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP

... & Kessler, LLP: Notice is hereby given that a class action lawsuit was filed in the United States ... to indicate the findings of PROVE 2 during the class Period, when the results became known. The ... Plaintiff seeks to recover damages on behalf of class members and is represented by the law firm of ...

Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients

... Toxicity Associated with Nucleoside class of HIV Drugs KENILWORTH, N.J., April 15 ... is a product in the protease inhibitor (PI) class of HIV medications. Truvada is a ... Med 2003; 349: 1993-2003. 8 The DAD study group. class of antiretroviral drugs and the risk of ...

Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA

... the safety profile of macrolides as a class represent patient and pharmacoeconomic benefits ... and drug discovery capabilities to create best in class small molecule drugs in the anti-infective field. ... the Company has created a new class of macrolide antibiotics, called Bicyclolides, ...

ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests

... inhibitors (NRTIs), a commonly used class of drugs to treat HIV. The HIV Pathogenesis ... is a pyrophosphate analog and member of a new class of reverse transcriptase inhibitor (RTI) that is ... is a pyrophosphate analog and member of a new class of reverse transcriptase inhibitor (RTI) that is ...

Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future

... review article entitled, "BiTE: A new class of antibodies that recruit T cells" in ... on BiTE antibodies, which are evolving into a new class of antibody-based therapeutics, with several new ... lymphoma. BiTE antibodies represent a new class of therapeutic antibodies that activate a ...

FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults

... first- line therapy compliance with a penicillin class of antibiotic." Clinical Trial Results Summary ... to amoxicillin or to other drugs in the same class or in patients who have demonstrated anaphylactic ... first once-daily product in the aminopenicillin class for the treatment of pharyngitis while ...

Roche responds to announcement of 'IDEAL' hepatitis C trial results

... histological evidence of cirrhosis (Child-Pugh class A) and patients with HIV disease that are ... histological evidence of cirrhosis (Child-Pugh class A). Alpha interferons, including PEGASYS ... decompensation (Child-Pugh score greater than 6; class B and C) in cirrhotic CHC monoinfected patients ...

Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)

... experience. Vidaza is the first of a new class of anti-cancer compounds known as demethylating ... 2004, the FDA approved Vidaza, the first in a new class of drugs called demethylation agents, for ... About Epigenetics Vidaza is the first of a new class of anti-cancer compounds known as epigenetic ...

Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin

... histological evidence of cirrhosis (Child-Pugh class A) and patients with HIV disease that are ... histological evidence of cirrhosis (Child-Pugh class A). Alpha interferons, including PEGASYS ... decompensation (Child-Pugh score greater than 6; class B and C) in cirrhotic CHC monoinfected patients ...

Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks

... a result of these findings. R1626 belongs to a class of antivirals called polymerase inhibitors, which ... histological evidence of cirrhosis (Child-Pugh class A) and patients with HIV disease that are ... histological evidence of cirrhosis (Child-Pugh class A). Alpha interferons, including PEGASYS(R) ...

Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development

... M.D., Chief Medical Officer of CTI. A new class of thienopyrimidine Src inhibitors demonstrates ... Src inhibitors may represent a new class of drugs with in vitro activity against chronic ... tumors display increased levels of Pi and Mu class of glutathione S-transferase and these data ...

FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia

... with known hypersensitivity to tetracycline class antibiotics. -- Glycylcycline class antibiotics are structurally similar to tetracycline class antibiotics and may have similar adverse effects. ...

Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension

... of Tracleer in mildly symptomatic (WHO Functional class II) PAH patients. This randomized, double-blind, ... for patients with World Health Organization (WHO) class III or IV PAH in the U.S., and Class III PAH in ... States for the treatment of patients with WHO class III or IV PAH. ...

Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination

... is an investigational compound that is part of a class of medications called fibrates. Fibrates have ... and moderately lower LDL-C. CRESTOR is part of a class of medication called statins, which has ... of the statin (HMG-CoA reductase inhibitors) class of drug therapy. CRESTOR has not been determined ...

Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV

... therapy. Atazanavir is a product in the protease inhibitor (PI) class of HIV medications. Truvada is a combination product in the ... infarction. N Engl J Med 2003; 349: 1993-2003. 6 The DAD study group. class of antiretroviral drugs and the risk of myocardial infarction. N Engl J ...

Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research

... the company has a strong and collaborative relationship with world class investigators at OHRI. Jennerex oncolytic virus products are being ... of action and the results in patients to date put the company's product class in a leadership position. Jennerex Biotherapeutics was established in San ...

Boehringer Ingelheim Unveils Diabetes Pipeline

... for the treatment of type 2 diabetes." DPP-4 inhibitors are a newer class of oral hypoglycemics that target the incretin hormones GLP-1 and GIP, ... co-transporter-2 inhibitors (SGLT-2 inhibitors), which are a new, emerging class of antidiabetic compounds that block tubular reabsorption of glucose in ...
Other Contents
(Date:9/18/2014)... their colleagues have built the first smartphone app ... and behavioral trends. In other words, your smartphone ... you don,t -- and how that affects you. ... stress, depression and loneliness to their academic performance, ... for example, to monitor mental health, trigger ...
(Date:9/18/2014)... which have devastated algal forests in the eastern Mediterranean ... basin if their distribution continues to expand as the ... an international team of researchers led by Dr Adriana ... the Mediterranean Institute for Advanced Studies in Spain, is ... of the team surveyed more than 1000 kilometres of ...
(Date:9/18/2014)... Becoming invisible is probably the ultimate form of camouflage: ... you. And this strategy is not as uncommon as ... Maryland Baltimore County, USA, explains that the larval life ... is one part of the anatomy that most creatures ... compound eyes have to shield each individual eye unit ...
Breaking Biology News(10 mins):New Dartmouth smartphone app reveals users' mental health, performance, behavior 2New Dartmouth smartphone app reveals users' mental health, performance, behavior 3New Dartmouth smartphone app reveals users' mental health, performance, behavior 4Tropical fish a threat to Mediterranean Sea ecosystems 2Transparent larvae hide opaque eyes behind reflections 2
(Date:9/19/2014)... Hastings and Hastings, a discount accident lawyer in Phoenix, ... record number of visitors to its new Phoenix personal injury ... cases as well as auto accident cases and slip & ... and others. Having served the state of Arizona for over ... time when it comes to dedicated and focused personal injury ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Boston Scientific ... mesh lawsuit ( http://www.transvaginalmeshlawsuithelp.com/ ) that is scheduled ... month, Bernstein Liebhard LLP reports. According to ... Court, the company asserts that claims involving its Solyx ... Practice and Remedies Code, a section of which shields ...
(Date:9/19/2014)... (HealthDay News) -- Although there is mounting evidence ... middle-aged and older adults in the United States ... to new research. Less than one-quarter of ... by the Department of Health and Human Services, ... for promoting health and fitness and staying independent, ...
(Date:9/19/2014)... York, NY (PRWEB) September 19, 2014 ... statin medication caused some patients to develop Type 2 ... litigation now underway in U.S. District Court, District of ... Status Report issued on September 12, 2014, discovery is ... things, the report noted that Pfizer, Inc., the manufacturer ...
(Date:9/19/2014)... In partnership with Raw Beauty NYC, OC healthcare agency ... social media efforts. StudioPMG is honored to be a part ... beauty as it applies to disabled women. , The ... and Vanessa Silberman, who wanted to create a photo exhibit ... Wendy Crawford, Susan Solman and Sabrina Cohen later joined in ...
Breaking Medicine News(10 mins):Health News:Hastings And Hastings Announces a Record Number of Visitors to Its New Phoenix Personal Injury Website 2Health News:Transvaginal Mesh Lawsuit Defendant Moves For Summary Judgment in Case Scheduled for Upcoming Texas Trial, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit Defendant Moves For Summary Judgment in Case Scheduled for Upcoming Texas Trial, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit Defendant Moves For Summary Judgment in Case Scheduled for Upcoming Texas Trial, Bernstein Liebhard LLP Reports 4Health News:Adults Over 45 Not Meeting U.S. Muscle Strengthening Guidelines, Study Says 2Health News:Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:OC Healthcare Agency StudioPMG Partners with The Raw Beauty Project ™ NYC 2014 2
Other TagsOther Tags